Clinical Trial Update: An Italian Multicentric Retrospective Observational Study to Assess Effectiveness and Safety of the Combination of Tafasitamab and Lenalidomide in Diffuse Large B-cell Lymphoma Patients Treated Under Named Patient Program

View source ↗

Summary

This clinical trial update notes an Italian multicenter retrospective observational study evaluating the effectiveness and safety of combining tafasitamab and l…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Diffuse Large B-cell Lymphoma

Drugs mentioned

• Monjuvi (tafasitamab)
• Revlimid (lenalidomide)

Snippet

Sponsor: IRCCS Azienda Ospedaliero-Universitaria di Bologna | Conditions: Diffuse Large B Cell Lymphoma (DLBCL) | Status: RECRUITING